← All patents

US20160122348A1

Compounds and anti-tumor nqo1 substrates

University of Texas System

Abstract

Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Paul J. Hergenrother
Priority date
October 14, 2011
Filing date
January 11, 2016
Publication date
May 05, 2016
Language
en
Metadata fetched
August 29, 2026 00:23